Recombinant proteins, peptide hormones, glycoproteins, and biologic preparations for research and institutional supply. This category falls under a distinct regulatory framework from peptide APIs. Availability, supply route, and applicable authorisation requirements are assessed on a per-compound and per-organisation basis. Enquiries welcome at this stage.